HQ Country
Filtered by:
7 Apr 2023

Athos Therapeutics

Athos Therapeutics, headquartered in California, is developing AI-based precision therapeutics to help patients suffering from chronic inflammatory diseases and cancer.
21 Oct 2022

Antibiotic Cement to Treat Bone Infections

Each year, 700,000 people die due to antibiotic resistance. A growing global population unfortunately generates a growing resistance to established antibiotic treatments — a threat that has been met with insufficient funding and dwindling inspiration, as commercial incentives for developing new antibiotics have fallen.
19 Aug 2022

Lithophane, 3D printing to Enable All Levels of Eyesight to See

A research team has taken a groundbreaking step forward in eliminating the exclusion of individuals with blindness from chemistry education and experiences. The researchers detail how they used lithophane - an old-fashioned art form - and 3D printing to turn scientific data into tactile graphics that glow with video-like resolution, enabling universal visualization of the same piece of data by both blind and sighted individuals.
6 Jul 2022

Algorithm Predicts Crime a Week in Advance

Advances in machine learning and artificial intelligence have sparked interest from governments that would like to use these tools for predictive policing to deter crime. Early efforts at crime prediction have been controversial, however, because they do not account for systemic biases in police enforcement and its complex relationship with crime and society.
7 Dec 2021

Paper Piano - Demonstrating Interactive NFC

Interactivity of NFC enhances the pallet of applications. prelonic boosted the capabilities by introducing a new quality of interactivity by using printed electronics.
20 Aug 2021

Machine Learning to Assess Risk of Schizophrenia in a Blood Sample

Schizophrenia is a devastating disease that affects about 1% of the world's population. Although genetic and environmental components seem to be involved in the condition, current evidence only explains a small portion of cases, suggesting that other factors, such as epigenetic, also could be important.
11 Jun 2021

GlaxoSmithKline, Progentec to Use AI and Wearables for Lupus Treatment

At least 5 million people worldwide are living with lupus, one of the most complex autoimmune diseases. It's difficult to diagnose and even more challenging to treat. Patient-generated data, including data from wearable devices, is becoming an integral part of chronic disease care as it enables continuous monitoring of pertinent health signals both in and outside of the clinic.
17 May 2021

Microneedle Patch Delivers Antibiotics Locally in the Skin

MRSA (methicillin resistant Staphylococcus aureus) skin infections are potentially lethal, especially in patients with compromised immune systems. Vancomycin is one of the main treatments and is given as an intravenous injection. The reason the antibiotic is not given locally is because of its low ability to penetrate the skin. It is not given orally either because of poor absorption through the gut.
14 May 2021

New Material Prevents Infections in Wounds

Researchers have developed a new material that prevents infections in wounds - a specially designed hydrogel, that works against all types of bacteria, including antibiotic-resistant ones. The new material offers great hope for combating a growing global problem.​
23 Apr 2021

Largest Solar Farm at an Australian University

The Microgrid at Deakin provides a unique opportunity to make a positive contribution in the collective fight against climate change while also conducting high-value research to benefit Australian communities.
8 Apr 2021

Screening for Skin Disease on Your Laptop

In artificial intelligence, deep learning organizes algorithms into layers (the artificial neural network) that can make its own intelligent decisions. To speed up the learning process, the new network was trained using the parameters of MobileNetV2, a mobile vision application, pre-trained on the ImageNet dataset with 1.4M images.
17 Mar 2021

Remote Controlled Microscale Robots to Deliver Drugs

Bionaut treatment modality uses remote-controlled microscale robots to deliver biologics, nucleic acids, or small molecule therapies locally to targeted brain disease areas.
16 Mar 2021

Living Lab of 200 Real World Smart Homes for Testing Electric Vehicles

Innovative companies developing smart home products or services that incorporate electric vehicle charging will benefit from a new offering in Energy Systems Catapult's real-world test environment - the Living Lab.
21 Dec 2020

Wideblue Shining a Light on Early Diagnosis of Sepsis

Wideblue, a Scottish-based medical device development specialist, is working alongside customer Anasyst and the Teesside University to develop a low-cost optical cavity absorption system which could potentially speed up the diagnosis of sepsis by a significant factor.
10 Dec 2020

Earbud Treats Rheumatoid Arthritis, Migraines, Postpartum Depression

Imagine a future in which earbuds could harness the power of the brain to regulate immune function and treat diseases like rheumatoid arthritis, depression, and migraine. Such is the ambition of Nēsos, a startup launching out of stealth today, following months of development. The team is pioneering a new method for the treatment of multiple diseases: via an earbud brain interface, proprietary electrical fields are delivered to the target brain areas that help control immune function.
16 Oct 2020

LIVMOR Receives FDA Clearance for the World's First Prescriptible Wear

Availability of physician-prescribed cardiac monitoring system will significantly improve screening and treatment of atrial fibrillation and other chronic heart conditions.
13 May 2020

Trial of Bioelectronic Platform in Rheumatoid Arthritis Patients

SetPoint Medical has received Investigational Device Exemption approval from the US Food and Drug Administration to study its proprietary bioelectronic platform in patients with rheumatoid arthritis.
16 Apr 2020

Subtle Medical

Unlike most AI radiology companies, Subtle Medical focuses on image acquisition rather than analysis. It is developing software solutions to improve the capture of high-quality medical images. More specifically, it transforms low resolution scans taken rapidly (eg: in 6 minutes) into high resolution scans that normally can only be obtained by running scans for 20+ minutes.
21 Nov 2019

Prelonic Launches PIP: Prelonic-Interactive-Paper

The recently developed mass production process for hybrid electronics allows the launch of products that combine mobile phones and paper.
25 Jul 2019

Process development for innovative products made of 2D nanomaterials

AIXTRON has successfully investigated the production, properties and applications of 2D nanomaterials in the "HEA2D" project together with five partners.